Trial · NCT03332771
Results by group44
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 44
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Hemoglobin A1c at Week 52 | Placebo | -0.40 | Standard Error 0.187 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c at Week 52 | Sotagliflozin 400 mg | -0.65 | Standard Error 0.101 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c at Week 52 | Sotagliflozin 200 mg | -0.49 | Standard Error 0.114 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c at Week 52 | Glimepiride | -0.61 | Standard Error 0.093 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c at Week 26 | Placebo | -0.41 | Standard Error 0.097 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c at Week 26 | Sotagliflozin 400 mg | -0.77 | Standard Error 0.076 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c at Week 26 | Sotagliflozin 200 mg | -0.61 | Standard Error 0.098 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c at Week 26 | Glimepiride | -1.02 | Standard Error 0.075 | percentage of HbA1c | |
| Change From Baseline in Body Weight at Week 26 and 52 | Placebo | Change at Week 26 | -1.26 | Standard Error 0.329 | kilogram (kg) |
| Change From Baseline in Body Weight at Week 26 and 52 | Sotagliflozin 400 mg | Change at Week 26 | -2.75 | Standard Error 0.257 | kilogram (kg) |
| Change From Baseline in Body Weight at Week 26 and 52 | Sotagliflozin 200 mg | Change at Week 26 | -2.24 | Standard Error 0.336 | kilogram (kg) |
| Change From Baseline in Body Weight at Week 26 and 52 | Glimepiride | Change at Week 26 | 0.70 | Standard Error 0.256 | kilogram (kg) |
| Change From Baseline in Body Weight at Week 26 and 52 | Placebo | Change at Week 52 | -0.47 | Standard Error 1.406 | kilogram (kg) |
| Change From Baseline in Body Weight at Week 26 and 52 | Sotagliflozin 400 mg | Change at Week 52 | -2.64 | Standard Error 0.503 | kilogram (kg) |
| Change From Baseline in Body Weight at Week 26 and 52 | Sotagliflozin 200 mg | Change at Week 52 | -1.74 | Standard Error 0.707 | kilogram (kg) |
| Change From Baseline in Body Weight at Week 26 and 52 | Glimepiride | Change at Week 52 | 0.94 | Standard Error 0.452 | kilogram (kg) |
| Change From Baseline in Systolic Blood Pressure (SBP) for Participants With SBP ≥130 mmHg at Week 12 | Placebo | -5.34 | Standard Error 1.451 | mmHg | |
| Change From Baseline in Systolic Blood Pressure (SBP) for Participants With SBP ≥130 mmHg at Week 12 | Sotagliflozin 400 mg | -8.03 | Standard Error 1.064 | mmHg | |
| Change From Baseline in Systolic Blood Pressure (SBP) for Participants With SBP ≥130 mmHg at Week 12 | Sotagliflozin 200 mg | -9.12 | Standard Error 1.466 | mmHg | |
| Change From Baseline in Systolic Blood Pressure (SBP) for Participants With SBP ≥130 mmHg at Week 12 | Glimepiride | -3.86 | Standard Error 1.081 | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03332771/results